TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q3 2023 vs. Q2 2023
How the institutions holding TriSalus Life Sciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 136.6K | +136.6K |
| Value | $0 | $699.3K | +$699.3K |
New holders (9)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connecticut Wealth Management, LLC | 57,188 | $292.8K | 0.02% |
| Anson Capital, Inc. | 35,005 | $179.2K | 0.34% |
| UBS Group AG | 24,932 | $127.7K | 0.00% |
| Geode Capital Management, LLC | 17,239 | $88.3K | 0.00% |
| Morgan Stanley | 1,137 | $5.82K | 0.00% |
| GPS Wealth Strategies Group, LLC | 657 | $3.36K | 0.00% |
| Wolverine Asset Management LLC | 415 | $2.12K | 0.00% |
| Wells Fargo & Company | 1 | $5 | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 1 | $5 | 0.00% |
Sold out (0)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.